Instrument Inactif

Autres langues Fusion IP plc

Actions

GB00B05L5X50

Gestion des placements et exploitants de fonds

Cours en clôture London S.E.
- ^GBX	-

Autres langues

19/03/14	Fusion IP : Court Confirmation of Capital Reduction and Effective Date
19/03/14	Fusion IP : Rule 2.10 Announcement
19/03/14	Fusion IP : Exercise of Options
06/03/14	Fusion IP plc : Rule 2.0 Announcement
27/02/14	Fusion IP plc : Results of the Court Meeting and General Meeting
25/02/14	Fusion IP plc : Further announcement 24th February – Scheme Document
24/01/14	Fusion IP plc : Fusion portfolio company Asalus awarded CE mark for Ultravision
14/11/13	Fusion IP plc : Phase Focus strengthens Board with New Chairman and Directors
18/07/13	Fusion IP plc : Absynth Biologics Limited secures £850,000 funding to develop its products
25/06/13	Fusion IP plc : Fusion portfolio company MedaPhor expands sales into China through major distribution agreement with Tellyes Scientific
20/06/13	Fusion IP plc : Fusion portfolio company, Diurnal, announces European Medicines Agency approval of Paediatric Investigation Plan
07/06/13	Fusion IP plc : Fault Current Limited awarded £635,000 grant from UK Government Department of Energy and Climate Change (DECC)
16/04/13	Fusion IP plc : INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 JANUARY 2013
10/04/13	Fusion IP plc : New Fusion portfolio company – PH Therapeutics Ltd
25/03/13	Fusion IP plc : Placing to raise £20 million, new university agreements and Notice of General Meeting
19/02/13	Fusion IP plc : Phase Focus, signs licensing agreement with Gatan, the world’s leading manufacturer of instrumentation for electron microscopes
05/02/13	Fusion IP plc : Fusion directors join board of Welsh £100 million investment fund, Arthurian
24/01/13	Fusion IP plc : Asalus successfully completes UltravisionTM ‘first-in-man’ clinical trial.
16/01/13	Fusion IP plc : Diurnal, successfully enrols first patient into CATCH Phase 2 trial
22/11/12	Fusion IP plc : Magnomatics raises £2.5m to fund the development of its magnetically geared motors for the hybrid and electric vehicle market
21/11/12	Fusion IP plc : Fusion portfolio company, MedaPhor, announces Riccardo Pigliucci as new chairman
17/10/12	Fusion IP plc : Preliminary Results for the tweleve months ended 31 July 2012
03/10/12	Fusion IP plc : Fusion portfolio company, i2L, acquires US based ICR to create global biocides laboratory and field trials contract research organisation
31/07/12	Fusion IP plc : New Fusion portfolio company – Fault Current Limited
20/06/12	Fusion IP plc : Zilico, announces £1m funding round for its cervical cancer diagnostic device